Solved

A New Estrogen Receptor Agonist Is Being Evaluated for the Treatment

Question 14

Multiple Choice

A new estrogen receptor agonist is being evaluated for the treatment of postmenopausal symptoms.  A prospective study shows that the drug increases the risk of deep vein thrombosis (DVT) in treated women who smoke compared to untreated women who smoke, with a relative risk (RR) of 1.70 and p-value of 0.01.  In nonsmokers, no increased risk of DVT is evident with use of the drug (RR = 0.96; p-value = 0.68) .  Which of the following describes this phenomenon?


A) Confounding
B) Effect modification
C) Latent period
D) Observer bias
E) Selection bias

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents